Should oral combination therapy be the standard of care for pulmonary arterial hypertension?

Expert Rev Respir Med. 2020 Apr;14(4):341-343. doi: 10.1080/17476348.2020.1722641. Epub 2020 Jan 28.

Authors

Aiko Ogawa¹, Hiromi Matsubara²

Affiliations

¹ Department of Clinical Science, National Hospital Organization Okayama Medical Center, Okayama, Japan.
² Department of Cardiology, National Hospital Organization Okayama Medical Center, Okayama, Japan.

PMID: 31983257
DOI: 10.1080/17476348.2020.1722641

No abstract available

Keywords: Combination therapy; epoprostenol; prognosis; prostacyclin; pulmonary arterial pressure; treatment algorithm.

Publication types

Editorial